Alkermes Medical Education Grants

Alkermes Medical Education Grants support educational initiatives aimed at enhancing patient care through continuing medical education. Proposals are invited for activities related to schizophrenia, bipolar disorder, narcolepsy, and idiopathic hypersomnia. Funding is available for various CME formats, focusing on practical training and understanding treatment complexities. Eligible applicants include U.S.-based organizations that are either non-profit or accredited CME providers. This initiative prioritizes innovative strategies to improve healthcare outcomes and knowledge dissemination.

NOTE: Submissions are due at least 90 days in advance of the activity date.
Alkermes Education Grants
Alkermes supports continuing medical education with grants for educational activities focused on pragmatic approaches to improving patient care and public health. We hope to contribute to an improved understanding of the underlying mechanisms of the diseases we research and their relevance to medications, as well as psychosocial interventions.
Grant funding may be available for activities, including live, print, enduring or web-based continuing medical education (CME) activities.
Alkermes is currently accepting grant proposals related to:

• SchizophreniaBipolar DisorderNarcolepsyIdiopathic Hypersomnia
• Schizophrenia and Bipolar Disorder Learners of interest:
• Nurse PractitionersPsychiatristsPrimary Care ProvidersPhysician AssistantsSocial WorkersPharmacists
• Narcolepsy and Idiopathic Hypersomnia Learners of interest:
• Sleep Medicine SpecialistsNeurologistsPsychiatrists PulmonologistsPediatricians Nurse PractitionersPrimary Care Providers
• Areas of Interest
• Alkermes is currently accepting proposals that address the topic areas listed below for Schizophrenia, Bipolar Disorder, Narcolepsy, and Idiopathic Hypersomnia
• Schizophrenia
• Understanding and implementing pharmacologic approaches to address one or more of the following challenges in the treatment of schizophrenia:
• Practical training in long-acting injectable (LAI) administration
• Optimizing patient treatment across stages of illness, including side effects and polypharmacy considerations
• Long term medication adherence strategies for long acting injectables
• Consideration of co-occurring disorders in treatment planning
• Bipolar Disorder

Understanding and implementing pharmacologic approaches to address one or more of the following challenges in the treatment of bipolar disorder:Optimizing patient treatment across stages of illness, including side effects and polypharmacy considerations
Treatment of mixed states
Long term medication adherence strategies for oral medications
Consideration of co-occurring disorders in treatment planning
Narcolepsy and Idiopathic Hypersomnia
Understanding the pathophysiology of, and the role of orexin neuropeptides in, Excessive Daytime Sleepiness (EDS), Narcolepsy and/or Idiopathic Hypersomnia
Clinical Strategies to improve earlier screening and diagnosis of patients with Narcolepsy and/or Idiopathic Hypersomnia
Elucidate the complexity of narcolepsy and/or Idiopathic Hypersomnia patients and their predisposed neurological, psychiatric, metabolic, endocrine, hepatic and GI co-morbidities

Eligibility

Only organizations based in the U.S. may apply. Medical education grants may be awarded to (i) nonprofit organizations with tax exempt status under the U.S. Internal Revenue Code or (ii) for-profit organizations that are accredited continuing medical education providers.Alkermes will consider support within the following therapeutic areas and disease states: Substance abuse, opioid dependence and mental & behavioral health.

Ineligibility

Alkermes’ educational grant funds may not be used to support overhead expenses of the applicant or for any other institution affiliated with the applicant.Alkermes will not support funding for meals, unless they are modest buffet meals, snacks or coffee that are made available to all attendees of the Educational Activity and where the identity of the Healthcare Participants who partake is not separately identifiable.Educational grants will not be awarded to or for:Individuals or a healthcare professional’s private practiceAny charity or foundation associated with or controlled by an individual healthcare professional or healthcare professional’s private practiceOrganizations that discriminate on the basis of race, color, sex, sexual orientation, religion, age, national origin or disabilityFundraising event of a potential customer (e.g., treatment center or hospital) where the proceeds are being used to cover general operational and routine business costsEvents that have already occurredPolitical organizations, campaigns and activitiesReligious organizations or groups whose activities are primarily sectarian in purposePrograms or proposals that supplement an organization’s income or offset its expenses in a manner that benefits, directly or indirectly, a physician’s compensationAlkermes does not provide support for education programs that are intended to encourage, induce, or influence any grant recipient to purchase, prescribe, refer, recommend, sell, administer, or arrange for the purchase, sale or recommendation, or formulary placement of any Alkermes’ product.